| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 53.65B | 53.69B | 56.47B | 67.54B | 54.43B | 67.68B |
| Gross Profit | 17.38B | 17.58B | 18.09B | 21.49B | 15.45B | 22.79B |
| EBITDA | 5.54B | 6.79B | 5.40B | 9.84B | 8.94B | 16.30B |
| Net Income | 3.99B | 3.59B | 4.27B | 6.71B | 5.03B | 9.65B |
Balance Sheet | ||||||
| Total Assets | 85.31B | 74.98B | 76.26B | 78.87B | 75.91B | 55.47B |
| Cash, Cash Equivalents and Short-Term Investments | 35.17B | 33.78B | 34.82B | 33.39B | 26.89B | 16.86B |
| Total Debt | 9.44B | 4.24B | 4.37B | 4.64B | 6.85B | 5.44B |
| Total Liabilities | 21.79B | 13.86B | 15.31B | 19.69B | 21.78B | 20.68B |
| Stockholders Equity | 57.76B | 55.47B | 55.10B | 53.83B | 48.57B | 29.62B |
Cash Flow | ||||||
| Free Cash Flow | 3.84B | 4.79B | 6.82B | 13.32B | -6.41B | 6.17B |
| Operating Cash Flow | 5.17B | 6.06B | 7.94B | 15.13B | -3.42B | 8.33B |
| Investing Cash Flow | -5.11B | -3.48B | -454.30M | -4.72B | -3.81B | -2.32B |
| Financing Cash Flow | -3.86B | -3.18B | -4.37B | -4.63B | 15.45B | -3.82B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
67 Neutral | HK$26.96B | 7.55 | 18.80% | 3.18% | 30.69% | -13.06% | |
66 Neutral | HK$1.00B | 5.43 | 41.54% | 1.89% | 44.93% | 18.38% | |
62 Neutral | HK$2.76B | 13.59 | 8.16% | 4.75% | 11.19% | 160.48% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
58 Neutral | HK$120.05B | 30.84 | 6.39% | 1.81% | 1.12% | 5.68% | |
45 Neutral | HK$26.25M | -0.09 | ― | ― | ― | ― | |
41 Neutral | HK$724.18M | -0.07 | ― | ― | 13.45% | 48.65% |